Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker

European Journal of Pediatrics

Volumn 170, Issue 5, 2011, Pages 657-660

  Renaud, Christian ^a   Ovetchkine, Philippe ^a   Bortolozzi, Patricia ^a   Saint Cyr, Claire ^a   Tapiero, Bruce ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Etanercept; Group A Streptococcus; Immunocompromised host; Purpura fulminans; Systemic juvenile idiopathic arthritis; Tumor necrosis factor inhibitor

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CLINDAMYCIN; CREATINE KINASE; DOBUTAMINE; DOPAMINE; ETANERCEPT; FRESH FROZEN PLASMA; HEMOGLOBIN; IMMUNOGLOBULIN; INDOMETACIN; LACTATE DEHYDROGENASE; METHOTREXATE; NORADRENALIN; PREDNISONE; VANCOMYCIN;

ADD ON THERAPY; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BLOOD EXAMINATION; BRAIN HEMORRHAGE; CASE REPORT; CAUSE OF DEATH; CHILD; CHILDHOOD DISEASE; CONFUSION; CREATINE KINASE BLOOD LEVEL; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; FEVER; FULMINATING PURPURA; GROUP A STREPTOCOCCAL INFECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; NEUTROPENIA; PRIORITY JOURNAL; PURPURA; RASH; SCHOOL CHILD; SKIN NECROSIS; STREPTOCOCCUS GROUP A; THROMBOCYTE TRANSFUSION; THROMBOCYTOSIS; VOMITING;

EID: 79955572360     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-010-1341-1     Document Type: Article

References (42)

1. Armbrust W, Kamphuis SS, Wolfs TW et al (2004) Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis. Rheumatology 43(4):527-529 (Pubitemid 38489378)
2. Baghai M, Osmon DR, Wolk DM et al (2001) Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clinic Proc 76(6):653-656 (Pubitemid 32525142)
3. Benítez-Macías JF, García-Gil D, Brun-Romero FM (2008) Fatal pneumococcal sepsis in patient with hidradenitis suppurative treated with infliximab. Med Clin (Barc) 131(20):799
4. Betrosian AP, Berlet T, Agarwal B (2006) Purpura fulminans in sepsis. Am J Med Sci 332(6):339-345 (Pubitemid 46005828)
5. Bongartz T, Sutton AJ, Sweeting MJ et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295(19):2275-2285 (Pubitemid 43736578)
6. Borrás-Blasco J, Nuñez-Cornejo C, Gracia-Perez A et al (2007) Parapharyngeal abscess in a patient receiving etanercept. Ann Pharmacother 41(2):341-344
7. Breda L, Del Torto M, De Sanctis S, Chiarelli F (2010) Biologics in children's autoimmune disorders: efficacy and safety. Eur J Pediatr. doi:10.1007/s00431-010-1238-z
8. Buckland GT 3rd, Carlson JA, Meyer DR (2007) Persistent periorbital and facial lymphedema associated with group A beta-hemolytic streptococcal infection (erysipelas). Ophthal Plast Reconstr Surg 23(2):161-163 (Pubitemid 46596617)
9. Carter JD, Kanik KS, Valeriano J (2000) Neck mass in a rheumatoid arthritis patient taking etanercept. J Clin Rheumatol 6(2):80-81 (Pubitemid 30226946)
10. Chan AT, Cleeve V, Daymond TJ (2002) Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J 78(915):47-48 (Pubitemid 34074917)
11. Choi KH, Yoo WH (2009) Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis. Rheumatol Int 29:463-466
12. Curtis JR, Patkar N, Xie A et al (2007) Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 56(4):1125-1133 (Pubitemid 46608637)
13. de Ridder L, Benninga MA, Taminiau JA et al (2007) Infliximab use in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 45(1):3-14 (Pubitemid 47012324)
14. Dhodapkar K, Corbacioglu S, Chang MW et al (2000) Purpura fulminans caused by group A beta-hemolytic Streptococcus sepsis. J Pediatr 137(4):562-567
15. Dixon WG, Symmons DP, Lunt M et al (2007) Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum 56(9):2896-2904 (Pubitemid 47502735)
16. Elwood RL, Pelszynski MM, Corman LI (2003) Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept. Pediatr Infect Dis J 22(3):286-288 (Pubitemid 36351083)
17. Farah R, Lisitsin S, Shay M (2006) Bacterial meningitis associated with infliximab. Pharm World Sci 28(3):123-125 (Pubitemid 44584043)
18. Goode S, Tierney G, Deighton C (2006) Life threatening intra-abdominal sepsis in patients on anti-TNF-alpha therapy. Gut 55 (4):590-591
19. Herrlinger KR, Borutta A, Meinhardt G et al (2004) Fatal staphylococcal sepsis in Crohn's disease after infliximab. Inflamm Bowel Dis 10(5):655-656 (Pubitemid 39276477)
20. Kapetanovic MC, Saxne T, Sjöholm A et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 45(1):106-111
21. Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098-1104
22. Killingley B, Carpenter V, Flanagan K, Pasvol G (2005) Pneumococcal meningitis and etanercept - chance or association? J Infect 51(2):E49-E51
23. Kirby AC, Raynes JG, Kaye PM (2005) The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. J Infect Dis 191(9):1538-1547 (Pubitemid 40563367)
24. Kroesen S, Widmer AF, Tyndall A, Hasler P (2003) Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology 42(5):617-621 (Pubitemid 37220869)
25. Lovell DJ, Giannini EH, Reiff A et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342(11):763-769 (Pubitemid 30151920)
26. Lovell DJ, Giannini EH, Reiff A et al (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48(1):218-226 (Pubitemid 36091666)
27. Lovell DJ, Reiff A, Jones OY et al (2006) Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 54(6):1987-1994 (Pubitemid 43877949)
28. Mohan AK, Coté TR, Block JA et al (2004) Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 39(3):295-299 (Pubitemid 39050474)
29. Mor A, Mitnick HJ, Greene JB et al (2006) Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis. J Clin Rheumatol 12(2):87-89 (Pubitemid 44309603)
30. Morishita K, Petty R, Cairns R et al (2010) Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-alpha therapy: a case series. Clin Rheumatol 29(6):677-681
31. Nuñez-Cornejo C, Borrás-Blasco J, Gracia-Perez A et al (2008) Septic shock and community-acquired pneumonia associated with etanercept therapy. Int J Clin Pharmacol Ther 46(4):193-197 (Pubitemid 351493990)
32. Opal SM, Cohen J (1999) Clinical Gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 27(8):1608-1616
33. Reichardt P, Dähnert I, Tiller G, Häusler HJ (2002) Possible activation of an intramyocardial inflammatory process (Staphylococcus aureus) after treatment with infliximab in a boy with Crohn disease. Eur J Pediatr 161(5):281-283 (Pubitemid 34492690)
34. Ritz MA, Jost R (2001) Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 7(4):327
35. Roos JC, Ostor AJ (2006) Orbital cellulitis in a patient receiving infliximab for ankylosing spondylitis. Am J Ophthalmol 141(4):767-769
36. Saketkoo LA, Espinoza LR (2006) Impact of biologic agents on infectious diseases. Infect Dis Clin North Am 20(4):931-961 (Pubitemid 44752020)
37. Serrano MS, Schmidt-Sommerfeld E, Kilbaugh TJ et al (2001) Use of infliximab in pediatric patients with inflammatory bowel disease. Ann Pharmacother 35(7-8):823-828 (Pubitemid 32678701)
38. Stephens MC, Shepanski MA, Mamula P et al (2003) Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol 98(1):104-111 (Pubitemid 36135177)
39. Sweet DD, Isac G, Morrison B et al (2007) Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate. CJEM 9(1):40-42 (Pubitemid 46277259)
40. Waguri-Nagaya Y, Kobayashi M, Goto H et al (2007) Septic arthritis of the right ankle caused by Staphylococcus aureus infection in a rheumatoid arthritis patient treated with etanercept. Mod Rheumatol 17(4):338-340 (Pubitemid 47263829)
41. Weinblatt ME, Abbott GF, Koreishi AF (2009) Case records of the Massachusetts General Hospital. Case 13-2009. A 54-year-old woman with respiratory failure and a cavitary lesion in the lung. N Engl J Med 360(17):1770-1779
42. Zimmer C, Beiderlinden M, Peters J (2006) Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis. Clin Rheumatol 25(3):430-432